OptimizeRx Corp. OPRX 深 滬
等待開盤 10-28 09:30:00 美东时间
20.88
-0.800
-3.69%
華盛通- 最 高22.25
- 今 開22.14
- 成交量 35.36万股
- 最 低 20.84
- 昨 收 21.68
- 總市值 3.88亿
- 52周最高 22.25
- 市盈率 靜 --
- 換手率 1.90%
- 52周最低 3.78
- 委 比 92.91%
- 總股本 1856.50万
- 歷史最高 99.178
- 量 比 1.58
- 振 幅 6.50%
- 歷史最低 3.78
- 每 手 1
- 風險率 5.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
JMP Securities Maintains Market Outperform on OptimizeRx, Raises Price Target to $23
JMP Securities analyst Constantine Davides maintains OptimizeRx (NASDAQ:OPRX) with a Market Outperform and raises the price target from $20 to $23.
10-10 20:51
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
OptimizeRx Corp. will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference on September 11, 2025, in New York, NY. The company, a leading healthcare technology provider, connects life science brands with patients and healthcare professionals through innovative AI-driven tools, ensuring privacy-safe and patient-centric solutions.
09-10 11:30
OptimizeRx Partners With Lamar Advertising To Revolutionize OOH Advertising For Pharmaceutical And Healthcare Brands
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare MarketingWALTHAM, Mass., Sept. 09, 2025
09-10 04:14
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
OptimizeRx and Lamar Advertising Company have formed a strategic partnership to enhance out-of-home (OOH) advertising for healthcare brands. By integrating OptimizeRx's patented Micro-Neighborhood Targeting (MNT) data with Lamar's全国户外广告网络，双方为制药企业提供精准的临床相关户外广告解决方案，同时保持成本效益和可衡量的结果。
09-09 20:05
OptimizeRx Appoints Brendan Merrell As COO
OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced
08-19 19:39
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading healthcare technology company, announced organizational updates and leadership advancements to accelerate its Rule of 40 strategy, balancing growth and profitability. CEO Steve Silvestro highlighted the Company’s confidence in its talent and commitment to strategic clarity. Key leadership changes include Ed Stelmakh as Chief Financial & Strategic Officer,...
08-19 11:30
Stifel Maintains Buy on OptimizeRx, Raises Price Target to $18
Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and raises the price target from $16 to $18.
08-08 22:30
OptimizeRx shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
OptimizeRx shares are trading higher after the company reported better-than-exp...
08-08 04:58
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
